INIS
management
100%
pregnancy
100%
etiology
100%
erythema
100%
patients
28%
drugs
28%
pathogenesis
14%
control
14%
inflammation
14%
risks
14%
corticosteroids
14%
surfaces
14%
symptoms
14%
malignancies
14%
tumor necrosis factor
14%
estrogens
14%
progesterone
14%
potassium iodides
14%
colchicine
14%
Keyphrases
Erythema Nodosum
100%
Therapeutic Management
100%
Salicylate
14%
Potassium Iodide
14%
Extensor
14%
Dapsone
14%
Panniculitis
14%
Tumour Necrosis Factor Inhibitor (TNFi)
14%
Risk-benefit Analysis
14%
Non-pharmacological
14%
Bandages
14%
Intralesional Corticosteroid
14%
Medicine and Dentistry
Erythema Nodosum
100%
Therapeutic Management
100%
Risk Benefit Analysis
14%
Potassium Iodide
14%
Dapsone
14%
Colchicine
14%
Lupus Erythematosus Panniculitis
14%
TNF Inhibitor
14%